New drug UCB9741 put to the test in healthy volunteers
NCT ID NCT06315335
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This early-stage study tested a single dose of the experimental drug UCB9741 in 40 healthy adults (Caucasian and Japanese) to check its safety and how the body processes it. Participants received either the drug or a placebo by injection. The goal was not to treat any disease, but to gather important safety information before future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Up0118 10001
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.